Navigation Links
UMMS and Lundbeck to explore potential targeted therapy for Huntington's disease
Date:1/28/2011

to human clinical trials. The study will evaluate potential dosing regimens of siRNA (small interfering RNA), packaged as short hairpin RNA (shRNA) and transported via the adeno-associated virus (AAV), a promising therapeutic vehicle for siRNA delivery to neurons. Additionally, researchers will work to establish the best brain distribution pattern for potential use of siRNA in clinical HD therapies. More specifically, a major element of the study will be to measure the volume of distribution in brain tissue of AAV-delivered shRNAmir (micro RNA-adapted shRNA).This will permit researchers to evaluate the dosing of AAV-shRNAmir in order to achieve spread throughout the striatum and nearby cortex.

"We've followed Dr. Aronin and his team of researchers at the Medical School for some time and have been inspired by their bold exploration of RNAi technology and its potential use as a therapy for HD," said Stevin Zorn, PhD, executive vice president, Lundbeck Research USA. "Lundbeck is proud to collaborate with such an exceptional group of scientists who are so devoted to those affected by this debilitating condition."

In addition to Dr. Aronin, a talented group of scientists comprise the UMMS research team, including: Guangping Gao, PhD, who brings vast experience in developing adeno-associated virus; Richard Moser, MD, a neurosurgeon with expertise in resection of brain tumors and accessing brain compartments; and Marian DiFiglia, PhD, of Massachusetts General Hospital, an expert in the neuropathology and mechanisms of HD. Consultants on the project include: Kitty Clarence-Smith, MD, PhD, Lundbeck Inc., a neuro-pharmacologist who was instrumental in the approval process of the first FDA-approved drug for HD chorea; Robert Friedlander, MD, Professor and Chair of Neurosurgery, University of Pittsburgh School of Medicine, who has expertise in the study of neuronal survival in HD; and Michael Levine, MD, Professor and Chair of the Neuro-Psychiatric Institu
'/>"/>

Contact: Alison Duffy
alison.duffy@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Gladstone and Lundbeck collaborate to study neurovascular disease
2. Explorers Bounty Puffed Fruit Snacks Helping Parents Battle Summer Obesity
3. Pittsburgh Neurosurgeons Explore Use of Drug that Illuminates Brain Tumor Cells To Guide Surgery
4. Unusual Place to Find Peace, Bliss and Explore Life's Mysteries
5. GE Healthcare, Intel and Mayo Clinic explore new models of health care delivery
6. DSM Personalized Nutrition Webinar Explores Benefits of Nutrition for Employee Health
7. Explore, Love, Happiness, Life Purpose, and Destiny with World Renowned Yogi and Mystic, Sadhguru
8. Lung cancer research explores the effects of patient attitudes on patient outcomes
9. Top Scientists Explore the Origin of Life in Annual Lasker Lecture at Scripps Research Institute Florida Campus
10. Study Explores Possibility of a Female Viagra
11. Health impacts of mobile phone use to be explored in huge new study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... Khanna Vision Institute is pleased to announce ... Helicopters holiday event for underprivileged kids. The highlight was ... by an aspen helicopter pilot. In the cover of ... was visible.(please see accompanying video). Helicopter pilots require great ... many pilots with Pi in eye vision correction. ...
(Date:12/21/2014)... HealthDay Reporter FRIDAY, Dec. 19, 2014 ... than traditional cigarettes, new research finds. Even though ... thousands of ex-smokers said they have fewer cravings and are ... to smoke, researchers reported. "The pattern was ... use than for tobacco use," said lead researcher Jonathan Foulds, ...
(Date:12/21/2014)... Francisco, California (PRWEB) December 21, 2014 ... his search for Vintage 1967 Jm Morrison and the Doors ... concert posters. This would also be the only time ... The concert was on Nov. 25, 1967. According to ... Washington D.C. They did play the Alexandria Roller Rink ...
(Date:12/21/2014)... Theme and plugin developers ... plugin for Final Cut Pro X entitled ProMotion. , ... more with absolute ease.” Said Christiana Austin, CEO of ... needed to easily animate their media inside FCPX.” , ... users to animate pictures, videos, logos, and more with ...
(Date:12/21/2014)... December 21, 2014 Concept Plus, LLC. ... firm headquartered in Fairfax, VA., today announced it has ... Fast 50 list, which ranks the fastest growing government contracting ... 2009 to 2013. , This is the first year that ... ranked # 20 with a 95.92% compound annual growth rate. ...
Breaking Medicine News(10 mins):Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2
... paclitaxel to standard chemo targets HER2-positive tumors , , WEDNESDAY, ... standard chemotherapy, the drug paclitaxel (Taxol) cuts the recurrence ... a particular form of tumor, a new study finds. ... produce an excess of the protein human epidermal growth ...
... decade later, study found , , WEDNESDAY, Oct. 10 (HealthDay News) ... a decade, with significantly lower death rates from cardiovascular disease ... taking the drug for years, a Scottish study found. , ... of patching up damage in the arteries and preventing progression ...
... Medical Center has been chosen as one of 14 ... Canada, the Agency for Healthcare Research and Quality (AHRQ) ... reviewed and reported on the content and quality of ... depression treatments, prostate cancer screening options, and surgical outcomes ...
... Have a Big Effect on Managing ... Diabetes Successfully, ... host, B. Smith, is encouraging people with type,2 diabetes to recognize ... managing diabetes successfully. Through the,Diabetes New Day campaign, supported by Merck ...
... Roxane Laboratories, Inc.,announced today the approval of ... Tablets, 150mg, 300mg and 600mg by the ... available in bottles of 100 tablets and ... and pharmacies,nationwide. (Logo: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO ...
... storm" in American,health has already hit. Over the past ... Fibromyalgia (FMS) has exploded by 400 to 1000,percent, as ... with,CFS in the U.S., previously estimated at 500,000, are ... placed the number of Americans,with FMS at 6 million. ...
Cached Medicine News:Health News:Drug a New Weapon Against One Form of Breast Cancer 2Health News:Drug a New Weapon Against One Form of Breast Cancer 3Health News:Statin Benefits Persist After Treatment Stops 2Health News:Statin Benefits Persist After Treatment Stops 3Health News:Vanderbilt Medical Center chosen as Evidence-based Practice Center 2Health News:Vanderbilt Medical Center chosen as Evidence-based Practice Center 3Health News:Video: Food Expert B. Smith to Provide Healthy Menu Makeovers 2Health News:Video: Food Expert B. Smith to Provide Healthy Menu Makeovers 3Health News:Video: Food Expert B. Smith to Provide Healthy Menu Makeovers 4Health News:Video: Food Expert B. Smith to Provide Healthy Menu Makeovers 5Health News:Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg 2Health News:'From Fatigued to Fantastic!' Provides Antidote to Energy Crisis 2
(Date:12/17/2014)... and SAN DIEGO , Dec. ... PHG ; AEX: PHIA) and Volcano Corporation (NASDAQ: ... measurement solutions for cardiovascular applications, today announced that they have ... Philips will commence a tender offer to acquire all of ... per share, or a total equity purchase price of USD ...
(Date:12/17/2014)... NASHVILLE, Tenn. , Dec. 17, 2014  Strategic ... health management software solutions, today announced a strategic agreement ... the New Jersey regional marketplace.  ... and enhance the health and wellness solutions QualCare brings ... and the surrounding region. QualCare ...
(Date:12/17/2014)... SCOTTSDALE, Ariz. , Dec. 17, 2014 /PRNewswire/ ... of state-of-the-art interactive music products, today announced that ... Ltd, a leading manufacturer and supplier of innovative ... As part of the agreement, RSL ... Facility bundled solution specifically configured for use within ...
Breaking Medicine Technology:Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3
... LITTLE FALLS, N.J., Nov. 5 CANTEL MEDICAL CORP. ... Krakauer, President & CEO, will be presenting at the Sidoti ... formal presentation is scheduled for 9:05 AM ET on Friday, ... a Q & A session immediately following the presentation. In ...
... Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... voreloxin orphan drug designation for the treatment of acute ... 2 clinical trials of voreloxin in AML: a single-agent ... elderly AML patients unlikely to benefit from standard induction ...
Cached Medicine Technology:Sunesis' Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia 2Sunesis' Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: